B12 and Proton Pump Inhibitors: Deficiency Risk (2026)

Updated: Oct 21, 2026Topvitamine
Proton pump inhibitors (PPIs) are widely used to treat acid reflux, but long-term use may increase your risk of vitamin B12 deficiency. This article explains the science behind this link, identifies who is most at risk, and offers actionable advice on monitoring and supplementing B12 safely. Get the facts and empower your health decisions.
B12 and Proton Pump Inhibitors: Deficiency Risk (2026) - Topvitamine

B12 Deficiency and Proton Pump Inhibitors: The Hidden Risk Explained

Proton pump inhibitors (PPIs) are among the most widely prescribed medications worldwide, offering relief to millions who suffer from acid reflux, GERD, and peptic ulcers. While these medications are generally safe and effective for short-term use, mounting evidence suggests a hidden nutritional consequence: B12 deficiency. This comprehensive guide explores the relationship between proton pump inhibitors and vitamin B12, explains who faces the greatest risk, and provides practical, evidence-based strategies for protecting your health while managing your digestive symptoms.

What Are Proton Pump Inhibitors and Why Are They Prescribed?

Proton pump inhibitors represent a class of medications that work by blocking the proton pump (the hydrogen-potassium ATPase enzyme system) in the parietal cells of the stomach lining. By irreversibly inhibiting this pump, PPIs dramatically reduce the production of gastric acid—often by 70% or more. This powerful acid suppression makes them highly effective for treating conditions where excess stomach acid causes harm.

Common PPI Medications

Several PPI medications are available, both by prescription and over-the-counter:

  • Omeprazole (Prilosec, Prilosec OTC)
  • Pantoprazole (Protonix)
  • Esomeprazole (Nexium)
  • Lansoprazole (Prevacid)
  • Rabeprazole (AcipHex)

Conditions Commonly Treated with PPIs

Doctors prescribe PPIs for a range of gastrointestinal conditions, including:

  • Gastroesophageal reflux disease (GERD) – The most common indication, characterized by stomach acid backing up into the esophagus
  • Peptic ulcer disease – Both gastric and duodenal ulcers benefit from acid suppression to promote healing
  • Erosive esophagitis – Inflammation and damage to the esophageal lining
  • H. pylori eradication – PPIs are used in combination with antibiotics to treat this infection
  • Zollinger-Ellison syndrome – A rare condition causing excessive acid production
  • Prevention of NSAID-induced ulcers – For patients who must take nonsteroidal anti-inflammatory drugs

Many people take PPIs for months or even years, often without regular reassessment of whether continued use is necessary. This long-term use is where concerns about nutrient absorption—particularly vitamin B12—become relevant.

Understanding Vitamin B12: Roles, Sources, and Daily Needs

Vitamin B12, also known as cobalamin, is an essential water-soluble vitamin that plays fundamental roles in human health. Unlike most vitamins, B12 is found almost exclusively in animal-derived foods, making it a nutrient of special concern for vegetarians and vegans.

Critical Functions of Vitamin B12

Vitamin B12 is involved in several vital physiological processes:

  • Red blood cell formation – B12 is essential for proper DNA synthesis during red blood cell development; deficiency leads to abnormally large, dysfunctional red blood cells (macrocytic anemia)
  • Neurological function – B12 maintains the myelin sheath that insulates nerve fibers, enabling efficient nerve signal transmission
  • DNA synthesis and cell division – B12 works with folate in one-carbon metabolism, crucial for DNA production and repair
  • Homocysteine metabolism – B12 helps convert homocysteine to methionine; elevated homocysteine is associated with cardiovascular and neurological risks

Dietary Sources of Vitamin B12

Natural food sources of B12 include:

  • Meat (beef, pork, poultry)
  • Fish and seafood (salmon, tuna, trout, clams)
  • Eggs
  • Dairy products (milk, cheese, yogurt)
  • Fortified foods (certain cereals, plant-based milks, nutritional yeast)

Recommended Daily Intake

The recommended dietary allowance (RDA) for vitamin B12 varies by age and life stage:

Population Group RDA for Vitamin B12
Adults (14+ years) 2.4 micrograms/day
Pregnant women 2.6 micrograms/day
Breastfeeding women 2.8 micrograms/day
Children (4-13 years) 1.2-1.8 micrograms/day

These recommendations assume normal absorption. For individuals with absorption difficulties—including those taking acid-suppressing medications—higher intakes or alternative delivery methods may be necessary.

How Do PPIs Cause Vitamin B12 Deficiency? The Science Explained

The connection between PPI use and B12 deficiency lies in the intricate process of vitamin B12 absorption. Understanding this mechanism helps explain why acid suppression can have unintended nutritional consequences.

The Role of Stomach Acid in B12 Absorption

Vitamin B12 in food is bound to proteins. To be absorbed, it must first be liberated from these protein complexes. This is where stomach acid becomes critical:

  1. Protein digestion – Gastric acid activates pepsin, a digestive enzyme that breaks down proteins, releasing B12 from its protein-bound form
  2. Binding to intrinsic factor – Once freed, B12 binds to a protein called intrinsic factor (IF), which is secreted by parietal cells in the stomach
  3. Ileal absorption – The B12-IF complex travels to the terminal ileum (the final section of the small intestine), where it is absorbed into the bloodstream

How PPI-Induced Acid Suppression Impairs B12 Absorption

When PPIs suppress stomach acid production, this carefully orchestrated process is disrupted. Without adequate gastric acid:

  • Pepsin is not properly activated, so protein-bound B12 remains trapped in protein complexes
  • B12 cannot be efficiently released from food sources
  • Less B12 binds to intrinsic factor, reducing absorption

Importantly, this mechanism primarily affects protein-bound B12 from food. Crystalline B12 in supplements—especially in high doses—is already in a free form that does not require acid for absorption. This distinction is crucial for understanding both the risk and the solution.

Additional Contributing Factors

Beyond reduced acid, other mechanisms may contribute to B12 deficiency in PPI users:

  • Small intestinal bacterial overgrowth (SIBO) – Reduced gastric acid may allow bacteria to proliferate in the small intestine, where they can compete for and consume B12 before it reaches the absorption site
  • Atrophic gastritis – Chronic inflammation of the stomach lining, which often coexists with conditions requiring PPIs, reduces both acid production and intrinsic factor secretion
  • H. pylori infection – This bacterium, which causes ulcers and is treated with PPIs, can also impair B12 absorption

Real-World Evidence: What Do Studies Say About PPI Use and B12 Deficiency?

The scientific literature has increasingly examined the relationship between long-term PPI use and vitamin B12 status. The evidence, while not uniform, suggests a meaningful association with important clinical implications.

Key Research Findings

A pivotal study published in JAMA in 2013 examined data from the National Health and Nutrition Examination Survey (NHANES). Researchers found that among adults aged 50 and older, those taking PPIs for more than two years had a significantly higher prevalence of vitamin B12 deficiency compared to those not taking these medications. The study reported that approximately 12% of long-term PPI users had B12 deficiency, compared to about 4% of non-users.

Another significant study in Alimentary Pharmacology & Therapeutics (2017) found that PPI users had a 65% increased risk of developing B12 deficiency over a five-year period, with risk increasing progressively with longer duration of use. This dose-response relationship strengthens the case for a causal association.

A systematic review and meta-analysis published in PLOS ONE (2019) confirmed these findings, demonstrating that PPI use was associated with a 42% higher risk of B12 deficiency. The meta-analysis included data from multiple countries and diverse patient populations, suggesting the finding is robust across different demographic groups.

Interpreting the Evidence

It is important to interpret this research with appropriate nuance:

  • Association does not prove causation – While observational studies show clear links, they cannot definitively establish that PPIs cause B12 deficiency in every case
  • Not everyone develops deficiency – Many long-term PPI users maintain normal B12 levels, suggesting individual variability in susceptibility
  • Duration matters – The risk appears most pronounced with use exceeding one to two years, though some vulnerable individuals may experience deficiency sooner
  • Indication may confound – People who need PPIs often have conditions (like atrophic gastritis or H. pylori infection) that independently impair B12 absorption

A 2022 review in Cleveland Clinic Journal of Medicine concluded that while the evidence supports an association between chronic PPI use and B12 deficiency, routine screening of all PPI users is not currently recommended. Instead, clinicians should maintain a high index of suspicion in patients with symptoms or additional risk factors.

Who Is Most at Risk for B12 Deficiency While Taking PPIs?

Not everyone taking a PPI will develop vitamin B12 deficiency. Certain factors significantly increase risk and warrant particular attention.

Age: The 65+ Factor

Adults over 65 face elevated risk for several reasons:

  • They are more likely to have atrophic gastritis, reducing baseline acid and intrinsic factor production
  • Aging itself is associated with increased prevalence of B12 deficiency
  • Older adults more frequently have conditions requiring PPI therapy
  • Polypharmacy (multiple medications) increases the likelihood of additional B12-depleting drugs

Dose and Duration of PPI Therapy

The risk of B12 deficiency increases with:

  • Higher doses – Daily or twice-daily dosing has greater impact on absorption than as-needed use
  • Extended duration – The risk becomes clinically meaningful after approximately 12-24 months of continuous use
  • Cumulative exposure – Even intermittent use over many years may contribute to deficiency

Existing Gastrointestinal Conditions

Several GI conditions compound the risk of PPI-related B12 deficiency:

  • Atrophic gastritis – Chronic inflammation that reduces acid and IF production
  • H. pylori infection – Currently or previously infected individuals may have altered B12 absorption
  • Celiac disease – Malabsorption issues affect multiple nutrients, including B12
  • Prior gastric surgery – Gastric bypass or resection reduces the stomach's ability to absorb B12
  • Crohn's disease or other inflammatory bowel conditions – May affect the terminal ileum where B12 is absorbed

Dietary Factors

Certain dietary patterns increase susceptibility:

  • Vegan and vegetarian diets – Lower dietary B12 intake provides less margin for absorption inefficiency
  • Low protein diets – Less protein-bound B12 is available from the diet
  • Poor overall nutrition – Malnutrition or limited food variety compounds risk

Other Medications

Several medications interact with B12 metabolism or absorption:

  • Metformin – This diabetes medication is associated with reduced B12 absorption (approximately 6-30% of long-term users develop deficiency)
  • Histamine H2 receptor blockers – While less potent than PPIs, these medications also reduce acid production
  • Colchicine and certain antibiotics – May affect intestinal absorption
  • High-dose vitamin C – May degrade B12 in the stomach when taken simultaneously

Individuals taking both PPIs and metformin warrant elevated vigilance, as the combination creates a dual risk for B12 deficiency. The multivitamin guide explores additional considerations for nutrient adequacy when taking multiple medications.

Recognizing the Symptoms of B12 Deficiency

Vitamin B12 deficiency develops gradually, and symptoms can be subtle in the early stages. Because B12 is stored in the liver and can last for years, clinical manifestations may not appear until stores are significantly depleted. Some individuals with deficiency are entirely asymptomatic, which is why laboratory testing is essential for at-risk populations.

Hematological Symptoms

B12 deficiency leads to megaloblastic anemia, characterized by:

  • Fatigue and weakness – The most common presenting symptoms
  • Shortness of breath – Particularly with exertion
  • Pale or jaundiced skin – Due to red blood cell breakdown
  • An enlarged spleen – Resulting from increased red blood cell destruction

Neurological and Psychiatric Symptoms

Neurological manifestations can be severe and may precede or occur independently of anemia:

  • Peripheral neuropathy – Tingling, numbness, or burning in hands and feet
  • Difficulty with balance and gait – Neurological impairment affecting coordination
  • Cognitive changes – Memory problems, difficulty concentrating, or confusion
  • Mood disturbances – Depression, irritability, or anxiety
  • Dizziness or vertigo – Related to neurological effects

Other Symptoms

Additional manifestations may include:

  • Smooth, beefy-red tongue (glossitis)
  • Mouth ulcers
  • Reduced appetite and weight loss
  • Constipation or diarrhea
  • Heart palpitations

In severe cases, untreated deficiency can lead to irreversible neurological damage, including subacute combined degeneration of the spinal cord. This underscores the importance of early detection and treatment in at-risk individuals.

Testing for B12 Deficiency: When and How to Get Checked

Given the subtlety of symptoms and the potential for asymptomatic deficiency, appropriate testing is essential for individuals at risk.

Who Should Be Tested?

Consider B12 testing if you:

  • Have taken a PPI continuously for more than one year
  • Take a PPI and have symptoms consistent with B12 deficiency
  • Use PPIs and have additional risk factors (age over 65, metformin use, vegetarian diet, GI disorders)
  • Have unexplained anemia, neuropathy, or cognitive changes

Available Tests

Test What It Measures Interpretation
Serum B12 Circulating vitamin B12 level Below 200 pg/mL generally indicates deficiency; 200-300 pg/mL is borderline
Methylmalonic acid (MMA) Metabolic marker of B12 status Elevated MMA suggests functional B12 deficiency
Homocysteine Amino acid that requires B12 for metabolism Elevated homocysteine suggests B12 deficiency
Complete blood count (CBC) Red blood cell size and count Macrocytic anemia (large RBCs) suggests B12 or folate deficiency

Interpreting Results

Serum B12 testing has limitations—it may not reflect tissue-level B12 status accurately. In borderline cases (200-300 pg/mL), measuring MMA and homocysteine provides additional information:

  • Normal MMA and homocysteine – Suggests adequate B12 status despite borderline serum levels
  • Elevated MMA or homocysteine – Suggests functional B12 deficiency requiring intervention

For patients with unexplained neurological symptoms despite normal serum B12, more advanced testing may be warranted. Discuss the appropriate testing strategy with your healthcare provider.

Managing B12 Levels While on PPIs: Practical Strategies

If you are taking a PPI and have concerns about B12, several strategies can help maintain adequate levels.

Oral B12 Supplementation

For most people, oral B12 supplements are effective even in the presence of acid suppression. This is because:

  • Crystalline B12 in supplements is already in free form—it does not require stomach acid for release
  • High doses create concentration gradients that allow for passive absorption, which does not depend on intrinsic factor
  • Even in individuals with significant malabsorption, approximately 1-2% of an oral dose is absorbed through passive diffusion

At doses of 500-1000 micrograms daily or weekly, this passive absorption pathway provides sufficient B12 for most individuals, even those taking PPIs long-term.

Choosing the Right Form

B12 supplements are available in several forms:

  • Cyanocobalamin – The most studied and stable synthetic form; FDA-approved for treating deficiency
  • Methylcobalamin – A naturally occurring form; popular but less evidence for superiority in PPI users
  • Hydroxocobalamin – Used in injectable form; long-acting
  • Adenosylcobalamin – Another naturally occurring form

For most PPI users, cyanocobalamin is an excellent choice due to its proven efficacy, stability, and affordability. Sublingual preparations may offer enhanced absorption for those with concerns about gastrointestinal uptake.

When Injections May Be Necessary

B12 injections may be appropriate for:

  • Severe deficiency with neurological symptoms
  • Confirmed malabsorption disorders (pernicious anemia, after gastric surgery)
  • Individuals who cannot or will not take oral supplements
  • Cases where oral supplementation fails to correct deficiency

Discuss the most appropriate delivery method with your healthcare provider.

Monitoring and Reassessment

For individuals on long-term PPI therapy:

  • Check B12 levels at baseline and periodically (e.g., annually) thereafter
  • Reassess the ongoing need for PPI therapy at each visit
  • Consider dose reduction or on-demand use if appropriate
  • Monitor for symptoms of deficiency even if prior levels were normal

Can Vitamin B12 Supplements Be Taken Safely with PPIs?

A common concern among PPI users is whether B12 supplements can be taken simultaneously without interference. The good news is that B12 supplements and PPIs do not have any direct negative interaction.

Is There Any Interaction?

The relationship between B12 supplements and PPIs is actually favorable:

  • PPIs do not destroy B12 supplements in the stomach
  • The free-form B12 in supplements is absorbed regardless of gastric acid levels
  • B12 is not an acidic molecule that requires acid for stability
  • No known adverse interactions exist between B12 and any PPI

Although acid is required to release B12 from food proteins, it is not needed to absorb the crystalline B12 found in supplements. This means you can take your B12 supplement at the same time as your PPI without concern.

Timing and Dosage Considerations

While no specific timing restrictions exist, a few practical tips:

  • Take B12 with food for better absorption if you tolerate it
  • If you take high-dose vitamin C, separate it from B12 by at least two hours (high-dose vitamin C may degrade B12)
  • Follow the dosage recommendations on the product label or as advised by your healthcare provider
  • For high-dose supplementation (1000 mcg+), consistency matters more than timing

B12 is water-soluble and safe at high doses because excess is excreted in urine. No upper limit has been established for B12 intake.

Lifestyle and Dietary Tips to Support B12 Levels

While supplementation is often necessary for PPI users, dietary and lifestyle strategies can help optimize B12 status.

Include B12-Rich Foods

Even with reduced absorption efficiency, consuming B12-rich foods remains beneficial:

  • Organ meats – Liver and kidney are exceptionally high in B12
  • Seafood – Clams, oysters, mussels, and fatty fish are excellent sources
  • Red meat – Beef provides substantial B12
  • Eggs and dairy – Good sources for those who include animal products
  • Fortified foods – Plant-based milks and cereals fortified with B12 offer options for vegetarians

Cooking Considerations

B12 is relatively stable but can be affected by cooking methods:

  • Avoid overcooking meat, which can reduce B12 content
  • Microwaving and steaming preserve more B12 than prolonged boiling
  • Limit water-based cooking methods that leach nutrients

Regular Monitoring

If you take a PPI long-term:

  • Request B12 testing as part of your annual health check
  • Track any symptoms that might suggest deficiency
  • Discuss your PPI use with all healthcare providers
  • Keep a medication list including all supplements

PPIs vs. Alternatives: Weighing the Risks and Benefits

For individuals concerned about B12 deficiency, it is reasonable to consider whether PPIs remain the best choice for managing their gastrointestinal symptoms. However, this decision should be made collaboratively with a healthcare provider.

When PPIs Are Essential

PPIs are appropriate and often necessary for:

  • Severe erosive esophagitis
  • Barrett's esophagus (a precancerous condition)
  • Active peptic ulcer disease
  • Prevention of bleeding in high-risk patients
  • Zollinger-Ellison syndrome
  • Part of H. pylori eradication therapy

In these situations, the benefits of acid suppression clearly outweigh potential nutritional risks.

Considering Alternatives

For milder conditions, alternatives may be worth discussing:

  • H2 receptor blockers (famotidine, ranitidine alternatives) – Provide moderate acid reduction with potentially less impact on B12 absorption
  • Antacids – For occasional symptom relief
  • Lifestyle modifications – Weight loss, elevating the head of the bed, avoiding trigger foods, eating smaller meals
  • On-demand PPI use – Taking PPIs only when symptoms flare rather than continuously

Some patients can transition from daily PPI use to on-demand therapy or step down to H2 blockers. This should be done gradually and under medical supervision to avoid rebound acid hypersecretion.

The Importance of Regular Reassessment

Many patients remain on PPIs indefinitely without reassessing the need. Guidelines recommend:

  • Periodic review of PPI indication
  • Attempting the lowest effective dose
  • Considering step-down therapy when appropriate
  • Evaluating whether gastrointestinal symptoms have resolved

Regular conversations with your doctor about ongoing PPI use are essential. If you are also taking medications like metformin or have additional risk factors, proactive monitoring becomes even more important. The vitamin D guide provides complementary information on nutrient considerations during long-term medication use.

Key Takeaways

  • Long-term use of proton pump inhibitors is associated with an increased risk of vitamin B12 deficiency, particularly with use exceeding one to two years
  • The mechanism involves reduced stomach acid impairing the release of B12 from food proteins, though supplement forms of B12 are still well absorbed
  • Older adults, those on higher doses or longer duration of PPI therapy, metformin users, and individuals with pre-existing GI conditions face the highest risk
  • B12 deficiency can cause fatigue, anemia, neuropathy, cognitive changes, and mood disturbances—but may be asymptomatic in early stages
  • Testing may include serum B12, methylmalonic acid, homocysteine, and complete blood count
  • Oral B12 supplements at doses of 500-1000 mcg are effective for most PPI users due to passive absorption mechanisms
  • B12 supplements can be taken safely alongside PPIs without negative interactions
  • Regular reassessment of PPI necessity and dose optimization can reduce risk while maintaining symptom control
  • Individuals on long-term PPIs should discuss B12 monitoring with their healthcare provider

Frequently Asked Questions

How common is B12 deficiency with PPI use?

Studies suggest that approximately 10-12% of long-term PPI users (more than two years) develop B12 deficiency, compared to about 4% of non-users. The risk increases with duration and dose of PPI therapy, as well as with additional risk factors like age and other medications.

Should I take B12 if I am on omeprazole?

If you have been taking omeprazole or another PPI for more than a year, particularly if you have additional risk factors, discussing B12 supplementation with your healthcare provider is reasonable. A daily supplement of 500-1000 mcg of cyanocobalamin is safe and effective for most people, even while continuing PPI therapy.

Can vitamin B12 trigger GERD?

There is no evidence that vitamin B12 supplements trigger or worsen GERD symptoms. B12 is not acidic and does not irritate the stomach or esophagus. If you experience digestive symptoms after taking B12, consider whether the supplement contains other ingredients that might be responsible, and discuss with your doctor.

Can you take B12 with proton pump inhibitors?

Yes, B12 supplements can be taken safely with PPIs. The crystalline form of B12 in supplements does not require stomach acid for absorption, so PPIs do not interfere with supplement absorption. There is no known interaction between B12 and any PPI medication.

How long does it take for B12 deficiency to develop with PPI use?

B12 deficiency typically develops gradually over months to years. The liver stores substantial amounts of B12—enough to last several years in some cases—so clinical deficiency may take 12-24 months or longer of continuous PPI use to manifest, depending on baseline stores, dietary intake, and individual factors.

Are there any other medications that increase B12 deficiency risk?

Beyond PPIs, medications associated with B12 deficiency include metformin (a common diabetes medication), H2 receptor blockers (like famotidine), colchicine, certain antibiotics, and high-dose vitamin C when taken with B12. Individuals taking multiple medications from this list should be particularly vigilant about monitoring.

What is the best form of B12 to take while on a PPI?

Cyanocobalamin is the most studied form and is highly effective for correcting deficiency, including in PPI users. Methylcobalamin and hydroxocobalamin are alternative forms that are also effective. For most people, standard cyanocobalamin supplements at adequate doses work well regardless of PPI use.

Can PPI-induced B12 deficiency be reversed?

Yes, B12 deficiency can typically be corrected with appropriate supplementation. Oral high-dose B12 or injections can restore normal levels. However, neurological symptoms that have been present for an extended period may not fully resolve, which is why early detection and treatment are important.

Do all PPIs affect B12 absorption equally?

All PPIs work through the same mechanism (blocking the proton pump) and have similar effects on acid suppression and B12 absorption. Omeprazole, pantoprazole, esomeprazole, and other PPIs are expected to have comparable impacts on B12 status when used at equivalent acid-suppressing doses.

Should I stop my PPI to protect my B12 levels?

Never stop a prescribed PPI without consulting your healthcare provider. PPIs are essential for managing serious conditions like erosive esophagitis, Barrett's esophagus, and peptic ulcers. Instead, discuss B12 monitoring and supplementation with your doctor, and explore whether dose reduction or alternative approaches are appropriate for your situation.

How often should I check my B12 levels if I take a PPI?

For long-term PPI users, checking B12 levels annually is a reasonable approach, especially if additional risk factors are present. If levels are borderline or symptoms are present, more frequent monitoring or additional testing (MMA, homocysteine) may be warranted. Discuss the appropriate schedule with your healthcare provider.

Can I get enough B12 from food while on a PPI?

Because PPIs impair the release of B12 from food proteins, relying on diet alone may be insufficient for some long-term users. While consuming B12-rich foods remains important, supplementation provides a reliable source of absorbable B12 that bypasses the acid-dependent step. Combining dietary sources with supplementation offers the best protection.

Conclusion: Stay Healthy and Informed

The relationship between proton pump inhibitors and vitamin B12 deficiency represents an important consideration for the millions of people who rely on these medications. While PPIs remain valuable and often necessary tools for managing acid-related conditions, awareness of their potential nutritional impact empowers patients and clinicians to take proactive steps.

If you take a PPI—especially for more than a year—consider discussing B12 monitoring with your healthcare provider. Simple blood tests can identify deficiency before symptoms become significant, and effective supplementation strategies are readily available. High-dose oral B12 supplements offer a convenient, safe, and effective solution for most people, even while continuing acid suppression therapy.

Remember that this information is educational and does not replace personalized medical advice. Your individual circumstances, including your reasons for taking a PPI, other medications, and overall health status, should guide decisions about supplementation and monitoring. Working collaboratively with your healthcare team ensures you receive the benefits of PPI therapy while protecting against potential nutritional consequences.

For additional information on supporting your nutritional status during long-term medication use, explore resources on vitamin C benefits and immune support and magnesium for energy and bone health.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, medication use, or dietary supplement before making changes to your health routine. The information provided is based on current scientific understanding but may not apply to your individual circumstances.

B12 deficiency, proton pump inhibitors and B12, PPI vitamin B12 deficiency, omeprazole B12 deficiency, long-term PPI use B12 deficiency, vitamin B12, cobalamin, PPI side effects, acid reflux medication nutrients, B12 absorption, B12 supplements with PPIs, methylmalonic acid, homocysteine, cyanocobalamin, atrophic gastritis, metformin B12, B12 deficiency symptoms, B12 testing, B12 management strategies, heartburn medication risks

More articles